Transcript Highlights:

• It allows the state to provide financial support to one or more pharmaceutical manufacturers for the

Bills: SB667 , SB904 , SB1344 , SB1380 , SB1423 , SB1425 , SB1484 , SB1500 , SB1502 , SB1503 , SB1555 , SB1561 , SB1562 , SB1565 , SB1572 , SB1644 , SB1749 , SB1833 , SB2007 , SB2044 , SB2074

Committee: House Public Health

Keywords: chiropractic, licensure, animal chiropractic, Board of Chiropractic Examiners, licensing requirements, gender transition, gender-affirming care, transgender, puberty blockers, cross-sex hormones, hormone therapy, sex reassignment, transition surgery, Medicaid, public funds, state facilities, state hospital, Oklahoma, intersex, DSD

Transcript Highlights:

• House Bill 1344 would allow the state to provide financial support to one or more pharmaceutical manufacturers

Bills: SB667 , SB904 , SB1344 , SB1380 , SB1423 , SB1425 , SB1484 , SB1500 , SB1502 , SB1503 , SB1555 , SB1561 , SB1562 , SB1565 , SB1572 , SB1644 , SB1749 , SB1833 , SB2007 , SB2044 , SB2074

Committee: House Public Health

Keywords: chiropractic, licensure, animal chiropractic, Board of Chiropractic Examiners, licensing requirements, gender transition, gender-affirming care, transgender, puberty blockers, cross-sex hormones, hormone therapy, sex reassignment, transition surgery, Medicaid, public funds, state facilities, state hospital, Oklahoma, intersex, DSD

Summary: The committee heard and advanced a large number of health-related bills, with much of the agenda focused on pharmacy benefit manager (PBM) regulation, Medicaid administration, and health-system cleanup measures. Bills passed included HB 1344 on insulin affordability and state support for low-cost biosimilar insulin manufacturing; HB 1380 requiring the Health Care Authority to check death records to disenroll deceased Medicaid recipients; SB 2007 and SB 2074, both PBM-related measures addressing pharmacist reimbursement, dispensing fees, appeals, and penalties; SB 1572 creating a feasibility study on reorganizing the Department of Mental Health and Substance Abuse Services and temporarily allowing the Health Commissioner to serve in a dual role; and SB 1555 updating the definition of intellectual disability to match the federal definition. Members also approved several bills eliminating or repealing outdated councils and programs, including SB 1423 ending the Hospital Advisory Council, SB 1425 repealing the Health Care Workers and Educators’ Assistance Program and Health Care Workforce Resources Center, and SB 1502 eliminating the Alzheimer Dementia Disclosure Act Advisory Council. Other measures passed included SB 1561 changing EMS discipline to a progressive system, SB 244 and SB 667 making chiropractic language and training cleanup changes, SB 1749 on LP gas inspections for food trailers, SB 1484 requiring more detailed medical information for infant and child death investigations, SB 1562 clarifying hospice patient protections, and SB 1644 creating reporting related to alpha-gal to support possible research funding. The most debated bill was SB 1503, which would expand the Choosing Childbirth Act so nonprofits without an Oklahoma physical address could receive grants to connect women seeking abortions with pregnancy resources. Members questioned whether grant dollars and salaries would stay in Oklahoma, whether reporting and accountability would be sufficient, and whether Oklahoma-based providers could do the work instead. The bill passed 5-2 after the sponsor said he was open to amendments and oversight. SB 1833, codifying a SNAP waiver restricting candy and soft drink purchases, and SB 904, modifying the use of certain state funds and facilities for medical procedures, also drew questions and passed on divided votes. The meeting ended after all listed bills were heard and voted on, with most measures passing unanimously or by wide margins.

Bills: HB5560 , HB2 , HB24 , HB3233 , HB1397 , HB2067 , HB3133 , HB5696 , HB5680 , HB2885 , HB3966 , HB3556 , HB3595 , HB144 , HB26 , HB2038 , HB521 , HB4 , HB 1178 , HB42 , HB 1211 , HB783 , HB3963 , HB2240 , HB1690 , HB 1234 , HB3372 , HB27 , HB4211 , HB2243 , HB2853 , HB4638 , HJR7 , HB 100 , HB 126 , HB3783 , HB5138 , HB2512 , HB5616 , HB4751 , SB17 , SB1637 , SB1833 , SB2155 , SB21 , SB2778 , SB260 , SB8 , SB12 , SB37 , SB379 , SB441 , SB1566 , SB2878 , HB4112 , HB3866 , HB4749 , HB2844 , HB150

Keywords: groundwater, civil penalties, water conservation, drought contingency, environmental protection, public education, teacher compensation, certification, funding, school finance, educator rights, education funding, charter schools, staff compensation, state aid, retention allotment, zoning, public notice, local government, residential development

Transcript Highlights:

• He doesn't completely agree with, so they shortened the sunset date for the Texas Pharmaceutical Initiative

Bills: HB5560 , HB2 , HB24 , HB3233 , HB1397 , HB2067 , HB3133 , HB5696 , HB5680 , HB2885 , HB3966 , HB3556 , HB3595 , HB144 , HB26 , HB2038 , HB521 , HB4 , HB 1178 , HB42 , HB 1211 , HB783 , HB3963 , HB2240 , HB1690 , HB 1234 , HB3372 , HB27 , HB4211 , HB2243 , HB2853 , HB4638 , HJR7 , HB 100 , HB 126 , HB3783 , HB5138 , HB2512 , HB5616 , HB4751 , SB17 , SB1637 , SB1833 , SB2155 , SB21 , SB2778 , SB260 , SB8 , SB12 , SB37 , SB379 , SB441 , SB1566 , SB2878 , HB4112 , HB3866 , HB4749 , HB2844 , HB150

Keywords: groundwater, civil penalties, water conservation, drought contingency, environmental protection, public education, teacher compensation, certification, funding, school finance, educator rights, education funding, charter schools, staff compensation, state aid, retention allotment, zoning, public notice, local government, residential development

Transcript Highlights:

• other ancillary products that come from petroleum, whether in the agricultural business, the pharmaceutical
• Petroleum, whether in the agricultural business, the pharmaceutical business, the tech business.
• bars up at the, you know, at their point of sale; they're getting pulled into this, so it's more expansive
• sustain an industry in a state by prohibiting A, growth; B, hardware sales, new hardware sales; and C, expansion
• Sale, new hardware sale, and expansion of any existing programs outside of the minimal recurring software

Keywords: 1146, all

Transcript Highlights:

• This is not a scope expansion bill, members.
• Expansion of scope. I don't know what is. I truly do not.
• As a physician, do you see this as a scope of practice expansion?
• Regarding scope expansion beyond just the scope expansion that it would automatically do through the
• So that is also an expansion.

Bills: SB1888 , SB3003 , SB2417 , SB2459 , SB3055 , HB1393 , HB2884 , SB2943

Committee: Senate State Affairs

Keywords: grand jury, jury qualifications, jury wheel, small counties, Texas legislation, age verification, obscene devices, online sales, juvenile protection, penalties, antitrust, attorney general, Texas Free Enterprise, business regulations, legal confidentiality, personal identifying information, data brokers, judicial safety, civil rights, data privacy

Transcript Highlights:

• Is it the same difference as far as cost is why generic, you know, pharmaceutical drugs, prescriptions
• I'm not an expert in the pharmaceutical space, but I would liken it to Cheetos versus cheese puffs.

Committee: Senate Energy, Utilities and Communications

Keywords: 987, senate, all

Transcript Highlights:

• And the federal government has not done the science, nor has the pharmaceutical industry, that needs
• With the swinging door policy of the FDA and pharmaceutical companies, it's very easy to see that.

Committee: House Health and Welfare

Keywords: 989, all

Transcript Highlights:

• On slide 14, you talk about the different pharmaceutical utilization management.
• is by far less... ...Drug A is by far the most expensive, which often happens in the world of pharmaceuticals

Summary: The Budget Committee met with a quorum and took up several bills. HB 677, relating to state-covered fertility preservation for employees undergoing cancer treatment, was introduced as coverage for egg and sperm preservation for up to three years, with an estimated fiscal impact of about $813,000. After brief questions and no public testimony or amendments, the bill passed unanimously and was reported favorably. The committee then considered CS/HB 59, which would reform Florida’s wrongful incarceration compensation process by extending the filing deadline from 90 days to two years, removing the clean-hands requirement, and allowing exonerees to choose between the state compensation process and a civil lawsuit; it was supported by the City of Flagler Beach and passed unanimously. CS/HB 1313, which recreates the Resilient Florida Trust Fund in the Department of Environmental Protection before its scheduled termination in 2025, also passed unanimously after supportive testimony from advocacy groups. The committee received a lengthy presentation from the Department of Management Services on the State Group Insurance Program and the recent Revenue Estimating Conference. The presentation covered enrollment, revenues and expenditures, rising medical and pharmacy costs, emergency room utilization, GLP-1 drug spending, and options for tighter formulary and utilization management. Members asked about ER cost growth, GLP-1 coverage and copays, PBM oversight and potential conflicts, avoidable ER visits, cancer screening claims, dental and vision costs, specialty drug biosimilars, and possible savings from more restrictive pharmacy models. DMS said it would follow up on several questions and noted ongoing work on cancer coordination, preventive screening, biomarker testing, and a proposed member-facing benefits platform. The committee also heard extensive testimony on HB 301, which would raise sovereign immunity caps from $200,000 per person and $300,000 per incident to $1 million and $3 million, align limitations periods with private claims, and allow government entities to settle above the caps without a claims bill. Local governments, school-related entities, and county and city associations opposed the bill, warning of major fiscal impacts, higher insurance costs, and pressure on services; several speakers urged smaller increases or a tiered approach. Proponents, including families affected by catastrophic injury or death, argued the current caps are too low and the claims bill process is inefficient and unfair. After debate, the bill passed on a recorded vote, with some members voting no, and was reported favorably.

Transcript Highlights:

• new coverage structures and billing mechanisms since this would be outside of the traditional pharmaceutical
• point out that insurers currently cover plenty of things also outside the traditional pharmacy, pharmaceutical

Committee: House House Health & Human Services

Transcript Highlights:

• they can use them in their practice, but when they go to the pharmacy... ...or they go to the pharmaceutical

Committee: Senate Health and Welfare

Keywords: 989, all

Transcript Highlights:

• When it comes to industries critical to our economic and national security, such as pharmaceuticals and
• </c> financial benefits for pharmaceutical financial benefits for pharmaceutical companies<04:13:48.319
• It was the first ever market incentive for pharmaceutical companies to develop childhood cancer treatments
• It was the first ever market incentive for pharmaceutical companies to develop childhood cancer treatments
• </c> ever market incentive for pharmaceutical ever market incentive for pharmaceutical companies<04:25

Keywords: U.S. House of Representatives Floor Proceedings on Monday, December 1, 2025, 1012, house, all

Transcript Highlights:

• mental health clinics, excluding those tied to the cannabis industry, psychedelic development, or pharmaceutical
• So I think, again, not to belabor the point, but this robust discussion, this expansive discussion, I
• I'm a scientist, a pharmaceutical professional, and the mother of three children, two of whom have been

Committee: Joint Joint Committee on Mental Health, Substance Use and Recovery

Keywords: 995, all

Summary: The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research. A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911. The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use. Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.

Transcript Highlights:

• is not matching up with avoiding those chronic diseases, and the money that has been spent on pharmaceuticals
• nutrition that's not matching up with avoiding those chronic diseases and the money that has spent on pharmaceuticals
• that were previously funded on a limited-term basis and do not represent any new programs or an expansion

Keywords: 988, house, all

Transcript Highlights:

• always partially taken, yes, home, but largely put back into investment, equipment, personnel, expansions
• another article that came out of 250 jobs lost in what was supposed to be our bread and butter in pharmaceuticals
• Jobs lost in what was supposed to be our bread and butter in pharmaceuticals, one of the largest employers

Bills: H5006 , H5007

Committee: Joint Special Joint Committee on Initiative Petitions

Keywords: tax revenue, state surplus, taxpayer refunds, budget growth, Massachusetts General Laws, income tax, tax reduction, state law, personal income tax, tax rates, 1212, all

Transcript Highlights:

• Her appointment and election have marked a historic expansion of representation within New Mexico's judiciary
• So certain medical equipment, stuff like that, for pharmaceuticals, stuff like that.
• Equipment, stuff like that, pharmaceuticals, stuff like that. Sorry, Mr.

Bills: HB145 , HB164 , HJR6 , HR1 , HB20 , HB65 , HB66 , HB80 , HB166 , HB295 , HB306 , SB29 , SB37 , HB99 , HB206 , HB213 , HB270 , HJR5 , SB104 , SB193 , HJM2 , HJM3 , HJM1 , HM7 , HM17 , HM4 , HM22 , HM23 , HM24 , HM26 , HM2 , HM16 , HM32 , HM13 , HM47 , HM20 , HM51 , HM1 , HM31 , HM35 , HM36 , HM46 , HM53 , HM54 , HM39 , HM11 , HM14 , HM21 , HM34 , HM50

Keywords: high-wage jobs, tax credit, job creation, New Mexico, economic development, lobbying, transparency, public records, government oversight, accountability, constitutional amendment, legislative sessions, veto override, New Mexico legislature, session length, House Resolution 1, HR1, House investigatory subcommittee, special committee, legislative investigation

Transcript Highlights:

• HB 4638 by Baudin relates to the Texas Pharmaceutical Initiative. Dr. Bonham, thank you Mr.
• This is the Texas Pharmaceutical Initiative, which we passed last session that is targeted to reducing
• HB 2310 by Rodriguez relating to developing a strategic plan for the improvement and expansion of early

Bills: HB200 , HB541 , HB1803 , HB30 , HB175 , HB249 , HB721 , HB851 , HB897 , HB 1128 , HB1904 , HB1916 , HB5560 , HB3071 , HB5627 , HB5435 , HB3913 , HB2921 , HB2695 , HB2688 , HB3045 , HB3483 , HB3673 , HB4213 , HB4226 , HB783 , HB4373 , HB4735 , HB5155 , HB5057 , HB4984 , HB4944 , HB4813 , HB5339 , HB5196 , HB5033 , HB4853 , HB3486 , HB4211 , HB74 , HB4670 , HB4730 , HB4743 , HB4603 , HB4463 , HB3892 , HB4139 , HB4752 , HB4520 , HB4517 , HB4486 , HB4437 , HB4426 , HB4396 , HB4263 , HB3487 , HB3418 , HB2284 , HB2266 , HB2229 , HB4912 , HB2189 , HB4506 , HB5269 , HB5224 , HB5195 , HB3317 , HB4166 , HB3947 , HB3358 , HB3370 , HB4438 , HB3745 , HB3602 , HB3697 , HB2001 , HB1968 , HB3371 , HB3909 , HCR7 , SB1744 , SB1364 , SB1316 , HB2026 , HB3302 , HB3368 , HB1639 , HB5652 , HB4655 , HB5654 , HB5658 , HB5656 , HB4894 , HB4996 , HB5088 , HB5650 , HB4464 , HB3751 , HB5665 , HB5661 , HB 1237 , HB2802 , HB5437 , HB2703 , HB5666 , HB5667 , HCR113 , HCR86 , SB2196 , SB463 , SB856 , SB1245 , SB1169 , SB509 , SB985 , SB305 , SB552 , HB1535 , HB 123 , HB1804 , HB426 , HB1773 , HB1871 , HB2035 , HB2492 , HB1411 , HB4753 , HB4666 , HB4529 , HB1499 , HB1610 , HB2028 , HB1506 , HB886 , HB3546 , HB796 , HB223 , HB3556 , HB2448 , HB4638 , HB 111 , HB180 , HB 1027 , HB 1178 , HB610 , HB 1277 , HB1615 , HB1620 , HB5342 , HB4885 , HB4751 , HB4530 , HB4488 , HB2149 , HB2071 , HB2282 , HB2248 , HB2243 , HB2522 , HB2310 , HB2513 , HB2300 , HB1902 , HB1813 , HB3719 , HB4284 , HB3743 , HB3778 , HB5153 , HB5147 , HB4877 , HB4850 , HB3261 , HB3005 , HB3033 , HB2849 , HB2967 , HB3531 , HB1768 , HB333 , HB2914 , HB2613 , HB3717 , HB3704 , HB2697 , HB3801 , HB3099 , HB3488 , HB3477 , HB3466 , HB3396 , HB3469 , HB2594 , HB2776 , HB2564 , HB2298 , HB5331 , HB5646 , HB5247 , HB5323 , HB4384 , HB3896 , HB4014 , HB3627 , HB3594 , HB2524 , HB510 , HB561 , HB5111 , HB5446 , HB 1181 , HB3963 , HB2785 , HB1661 , HB2460 , HB200 , HB541 , HB1803 , HB30 , HB175 , HB249 , HB721 , HB851 , HB897 , HB 1128 , HB1904 , HB1916 , HB5560 , HB3071 , HB5627 , HB5435 , HB3913 , HB2921 , HB2695 , HB2688 , HB3045 , HB3483 , HB3673 , HB4213 , HB4226 , HB783 , HB4373 , HB4735 , HB5155 , HB5057 , HB4984 , HB4944 , HB4813 , HB5339 , HB5196 , HB5033 , HB4853 , HB3486 , HB4211 , HB74 , HB4670 , HB4730 , HB4743 , HB4603 , HB4463 , HB3892 , HB4139 , HB4752 , HB4520 , HB4517 , HB4486 , HB4437 , HB4426 , HB4396 , HB4263 , HB3487 , HB3418 , HB2284 , HB2266 , HB2229 , HB4912 , HB2189 , HB4506 , HB5269 , HB5224 , HB5195 , HB3317 , HB4166 , HB3947 , HB3358 , HB3370 , HB4438 , HB3745 , HB3602 , HB3697 , HB2001 , HB1968 , HB3371 , HB3909 , HCR98 , HCR92 , HCR126 , HCR7

Keywords: juvenile offenders, parole eligibility, youth justice, criminal justice reform, inmate rehabilitation, direct patient care, healthcare, physicians, medical services, insurance regulation, dentist, dental hygienist, interstate practice, licensure, compact privilege, public health, military members, disaster relief, tax rates, local government

Transcript Highlights:

• The pharmaceuticals subcommittee will be meeting at 9:15 on Zoom tomorrow morning. >> All right.
• <02:20:45.040><c> subcommittee</c><02:20:45.600><c> meeting</c> pharmaceutical subcommittee meeting pharmaceutical
• Speaker.<02:21:11.360><c> Uh</c><02:21:11.440><c> the</c><02:21:11.600><c> pharmaceuticals</c><02:21:
• Uh the pharmaceuticals uh Speaker.
• Uh the pharmaceuticals uh subcommittee<02:21:13.160><c> will</c><02:21:13.400><c> be</c><02:21:13.560

Keywords: House streaming session for Friday, April 10, 2026, 957, house, all

Transcript Highlights:

• When this additional expansion was proposed last year, we were able to in-house update that.
• When this additional expansion was proposed last year, we were able to in-house update that.
• Fiscal consequences and government expansion.
• Um fiscal consequences<03:01:04.240><c> and</c><03:01:04.399><c> government</c><03:01:04.800><c> expansion
• </c> consequences and government expansion. consequences and government expansion.

Committee: Senate Health and Human Services

Keywords: 1191, senate, all

Bills: SB 2 , HB 2 , HB 2000 , HB 2196 , HB 213 , HB 222 , HB 645 , HB 1458 , HB 1022 , HB 141 , HB 502 , HB 643 , HB 3093 , HB 1700 , HB 117 , SB 503 , SB 2 , HB 120 , HB 20 , HB 150 , HB 6 , HB 100 , HB 210 , HB 215 , HB 1393 , HB 1151 , HB 1268 , HB 142 , HB 451 , HB 124 , HB 2 , HB 2000 , HB 2196 , HB 213 , HB 222 , HB 645 , HB 1458 , HB 1022 , HB 141 , HB 502 , HB 643 , HB 3093 , HB 1700 , HB 117

Keywords: public education, teacher compensation, certification, funding, school finance, educator rights, education funding, charter schools, staff compensation, state aid, retention allotment, child grooming, sex offender registration, criminal justice, reportable conviction, law enforcement, virtual education, hybrid learning, school funding, average daily attendance